A new biodegradable crosslinked polyethylene oxide sulfide (PEOS) hydrogel for controlled drug release

Int J Pharm. 2009 Jun 5;374(1-2):58-65. doi: 10.1016/j.ijpharm.2009.03.010. Epub 2009 Mar 19.

Abstract

We developed a polyethylene glycol (PEG)-based biodegradable hydrogel through disulfide crosslinking of polyethylene oxide sulfide (PEOS). The crosslinking rate was highly dependent on temperature, and incubation at about 40-50 degrees C was required for efficient crosslinking. The crosslinked PEOS hydrogel showed glutathione-dependent dissolution and corresponding controlled release of a model drug-fluorescein isothiocyanate (FITC)-labeled dextran-because the disulfide bond, the main linker, is selectively degraded in response to the high concentration of glutathione. The temperature-sensitive crosslinking and the hydrogel formation have the potential for use as an injectable biogel precursor, which was confirmed by in situ gel formation in mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cross-Linking Reagents / chemistry
  • Delayed-Action Preparations
  • Dextrans / administration & dosage*
  • Drug Carriers / chemistry
  • Fluorescein-5-isothiocyanate / administration & dosage
  • Fluorescein-5-isothiocyanate / analogs & derivatives*
  • Glutathione / metabolism
  • Hydrogels
  • Injections, Subcutaneous
  • Mice
  • Mice, Inbred C57BL
  • Polyethylene Glycols / chemistry*
  • Sulfides / chemistry*
  • Temperature

Substances

  • Cross-Linking Reagents
  • Delayed-Action Preparations
  • Dextrans
  • Drug Carriers
  • Hydrogels
  • Sulfides
  • fluorescein isothiocyanate dextran
  • Polyethylene Glycols
  • Glutathione
  • Fluorescein-5-isothiocyanate